Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pepdite AA Module powder
0913354A0BCAAAB
|
Pepdite powder disc infant formula for malabsorption | Powder disc infant formula for malabsorption (0913354) | Nutrition and Blood | No data available |
|
Pepdite powder
0913354A0BCABAC
|
Pepdite powder disc infant formula for malabsorption | Powder disc infant formula for malabsorption (0913354) | Nutrition and Blood | No data available |
|
Peppermint emulsion concentrated
190400000AAAUAU
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Peptamen liquid unflavoured
0913061B0BCABAB
|
Peptamen ready to serve 1 kcal/ml milkshake | Ready to serve 1 kcal/ml milkshake (0913061) | Nutrition and Blood | No data available |
|
Peptimax 200 tablets
0103010D0BDAAAA
|
Peptimax | Cimetidine | Gastro-Intestinal System | No data available |
|
Peptimax 400 tablets
0103010D0BDABAB
|
Peptimax | Cimetidine | Gastro-Intestinal System | No data available |
|
Perampanel 2mg/5ml oral suspension
0408010AKAAAKAK
|
Perampanel | Perampanel | Central Nervous System | No data available |
|
Perampanel 4mg/5ml oral suspension
0408010AKAAAGAG
|
Perampanel | Perampanel | Central Nervous System | No data available |
|
Perampanel 5mg/5ml oral suspension
0408010AKAAAIAI
|
Perampanel | Perampanel | Central Nervous System | No data available |
|
Perampanel 6mg/5ml oral suspension
0408010AKAAAHAH
|
Perampanel | Perampanel | Central Nervous System | No data available |
|
Percutol 2% ointment
0206010F0BHAAAF
|
Percutol | Glyceryl trinitrate | Cardiovascular System | No data available |
|
Perdix 15mg tablets
0205051C0BBABAB
|
Perdix | Moexipril hydrochloride | Cardiovascular System | No data available |
|
Perdix 7.5mg tablets
0205051C0BBAAAA
|
Perdix | Moexipril hydrochloride | Cardiovascular System | No data available |
|
Perfalgan 1g/100ml solution for infusion vials
0407010H0CMAADI
|
Perfalgan | Paracetamol | Central Nervous System | No data available |
|
Perfalgan 500mg/50ml solution for infusion vials
0407010H0CMABDK
|
Perfalgan | Paracetamol | Central Nervous System | No data available |
|
Perfan 100mg/20ml solution for injection ampoules
0201020G0BBAAAA
|
Perfan | Enoximone | Cardiovascular System | No data available |
|
Pergolide 1mg tablets
0409010P0AAACAC
|
Pergolide mesilate | Pergolide mesilate | Central Nervous System | No data available |
|
Pergolide 250microgram tab and Pergolide 50microgram tab
0409010P0AAAEAE
|
Pergolide mesilate | Pergolide mesilate | Central Nervous System | No data available |
|
Pergolide 250microgram tablets
0409010P0AAABAB
|
Pergolide mesilate | Pergolide mesilate | Central Nervous System | No data available |
|
Pergolide 50microgram tablets
0409010P0AAAAAA
|
Pergolide mesilate | Pergolide mesilate | Central Nervous System | No data available |
|
Pergoveris 150unit/75unit inj vials
0605010ABBBAAAA
|
Pergoveris | Follitropin alfa and lutropin alfa | Endocrine System | No data available |
|
Pergoveris 450units/225units/0.72ml inj pre-filled pens
0605010ABBBABAB
|
Pergoveris | Follitropin alfa and lutropin alfa | Endocrine System | No data available |
|
Peri-Prep wipes
23804108009
|
Peri-Prep wipes | Skin Fillers And Protectives | Stoma Appliances | No data available |
|
Pericyazine 2.5mg/5ml oral liquid
0402010P0AAAGAG
|
Pericyazine | Pericyazine | Central Nervous System | No data available |
|
Perindopril erbumine 1mg/5ml oral liquid
0205051M0AAACAC
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.